Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas [Seeking Alpha]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Seeking Alpha
Despite efforts to improve perceptions around its sequencing accuracy, Pacific still faces apparent skepticism from its customer base. Q1 earnings reflect challenges with low gross margins and high SG&A costs, highlighting financial strains. High operational and financial risks suggest a 'sell' recommendation for Pacific Biosciences' stock. Challenges and Competition in Pacific Biosciences' Sequencing Technology Pacific Biosciences of California NASDAQ: PACB ) specializes in genetic sequencing technology. The company is well-known for its Single Molecule, Real-Time [SMRT] sequencing technology, which enables long-read sequencing capabilities. However, compared to competitors like Recommended For You Recommended For You About PACB Stock More on PACB Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California, Inc (PACB): A Good Buy According to Analysts? [Yahoo! Finance]Yahoo! Finance
- Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices [Yahoo! Finance]Yahoo! Finance
- Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best PracticesAccesswire
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
PACB
Earnings
- 5/9/24 - In-Line
PACB
Sec Filings
- 6/20/24 - Form 4
- 6/20/24 - Form 4
- 6/20/24 - Form 4
- PACB's page on the SEC website